I Need Mental Help, Nothing is Working and Hair Loss Lives in My Head Rent Free
    4/14/2025

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg 1x daily since February 2025
    💧 Finasteride (topical) from June 2024 to February 2025
    💊 Minoxidil (oral) from January 2024 to October 2024
    💧 Minoxidil (topical) since October 2024
    💊 Magnesium Glycinate (oral) recently started
    the tone is 😞 negative with no growth results.

    Other terms

    A person is struggling with hair loss despite using finasteride and minoxidil, considering dutasteride and magnesium supplements. They are advised to be patient, consider a hair transplant, and check for thyroid issues.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research A Review on Herbal Drugs Used For Hair Growth Promotion

      May 2026 in “International Journal of Drug Delivery Technology”
      This source describes how androgenic alopecia, or pattern hair loss, affects about 70% of men and is linked to factors like stress, hormonal imbalances, and lifestyle issues, which can also impact psychological well-being and potentially contribute to severe health conditions such as heart disease.

      research Relatório de Estágio realizado na Farmácia Santiago

      September 2018 in “Open Repository of the University of Porto (University of Porto)”
      This report reviews a pharmacy internship in Oliveira de Azeméis, detailing the development of skills, practical projects on health topics, and contributions to the pharmacy’s social media presence, with no new clinical results reported.

      research Androgenetic Alopecia: A Review

      April 2024 in “Nigerian Postgraduate Medical Journal”
      This review summarizes existing knowledge on androgenetic alopecia, including its epidemiology, pathophysiology, and management, but presents no new research findings.

      research Farmácia do Lago, Porto e nos Serviços Farmacêuticos do Nemocnica Akademika Ladislava Dérera (Kramáre Hospital), Eslováquia

      December 2024 in “Open Repository of the University of Porto (University of Porto)”
      This study consisted of a pharmacy master's thesis detailing practical experiences during a hospital and community pharmacy internship and scientific investigations into the off-label use of dutasteride for androgenetic alopecia and oral vaccines for urinary tract infection prophylaxis, emphasizing therapeutic applications and mechanisms of action.